Literature DB >> 16631163

Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro.

Lynda S Wright1, Karen R Prowse, Kyle Wallace, Maarten H K Linskens, Clive N Svendsen.   

Abstract

Isolation of a true self-renewing stem cell from the human brain would be of great interest as a reliable source of neural tissue. Here, we report that human fetal cortical cells grown in epidermal growth factor expressed low levels of telomerase and telomeres in these cultures shortened over time leading to growth arrest after 30 weeks. Following leukemia inhibitory factor (LIF) supplementation, growth rates and telomerase expression increased. This was best demonstrated following cell cycle synchronization and staining for telomerase using immunocytochemistry. This increase in activity resulted in the maintenance of telomeres at approximately 7 kb for more than 60 weeks in vitro. However, all cultures displayed a lack of oligodendrotye production, decreases in neurogenesis over time and underwent replicative senescence associated with increased expression of p21 before 70 weeks in vitro. Thus, under our culture conditions, these cells are not stable, multipotent, telomerase expressing self-renewing stem cells. They may be more accurately described as human neural progenitor cells (hNPC) with limited lifespan and bi-potent potential (neurons/astrocytes). Interestingly, hNPC follow a course of proliferation, neuronal production and growth arrest similar to that seen during expansion and development of the human cortex, thus providing a possible model neural system. Furthermore, due to their high expansion potential and lack of tumorogenicity, these cells remain a unique and safe source of tissue for clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631163     DOI: 10.1016/j.yexcr.2006.03.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  45 in total

Review 1.  Cellular models for disease exploring and drug screening.

Authors:  Zhi-Kun Li; Qi Zhou
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

2.  Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

Authors:  Marianela Candolfi; Weidong Xiong; Kader Yagiz; Chunyan Liu; A K M G Muhammad; Mariana Puntel; David Foulad; Ali Zadmehr; Gabrielle E Ahlzadeh; Kurt M Kroeger; Matthew Tesarfreund; Sharon Lee; Waldemar Debinski; Dhruv Sareen; Clive N Svendsen; Ron Rodriguez; Pedro R Lowenstein; Maria G Castro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-28       Impact factor: 11.205

3.  Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF.

Authors:  Soshana Behrstock; Allison D Ebert; Sandra Klein; Melanie Schmitt; Jeannette M Moore; Clive N Svendsen
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

4.  Regulation of prenatal human retinal neurosphere growth and cell fate potential by retinal pigment epithelium and Mash1.

Authors:  David M Gamm; Lynda S Wright; Elizabeth E Capowski; Rebecca L Shearer; Jason S Meyer; Hyun-Jung Kim; Bernard L Schneider; John Nicholas Melvan; Clive N Svendsen
Journal:  Stem Cells       Date:  2008-09-18       Impact factor: 6.277

Review 5.  Stem cell-based therapies for spinal cord injury.

Authors:  Rishi S Nandoe Tewarie; Andres Hurtado; Ronald H Bartels; Andre Grotenhuis; Martin Oudega
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

6.  Overexpression of basic helix-loop-helix transcription factors enhances neuronal differentiation of fetal human neural progenitor cells in various ways.

Authors:  Angéline Serre; Evan Y Snyder; Jacques Mallet; Delphine Buchet
Journal:  Stem Cells Dev       Date:  2011-07-18       Impact factor: 3.272

7.  Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.

Authors:  Ajay K Yadav; Jaclyn J Renfrow; Denise M Scholtens; Hehuang Xie; George E Duran; Claudia Bredel; Hannes Vogel; James P Chandler; Arnab Chakravarti; Pierre A Robe; Sunit Das; Adrienne C Scheck; John A Kessler; Marcelo B Soares; Branimir I Sikic; Griffith R Harsh; Markus Bredel
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

8.  Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform.

Authors:  Jonathan Riley; Thais Federici; John Park; Masatoshi Suzuki; Colin K Franz; Craig Tork; Jacalyn McHugh; Qingshan Teng; Clive Svendsen; Nicholas M Boulis
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

Review 9.  Stem cell sources and therapeutic approaches for central nervous system and neural retinal disorders.

Authors:  Diana Yu; Gabriel A Silva
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

10.  Chromosome 7 and 19 trisomy in cultured human neural progenitor cells.

Authors:  Dhruv Sareen; Erin McMillan; Allison D Ebert; Brandon C Shelley; Julie A Johnson; Lorraine F Meisner; Clive N Svendsen
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.